Publication | Closed Access

Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses

InflammationBiochemistryCardiovascular DiseaseMedicineLipid PeroxidationPhysiologyDiabetesDiabetes ComplicationsDiabetic CardiomyopathyDiabetes MellitusNrf2-mediated Antioxidant ResponsesPharmacologyInsulin SignalingNf-κb-mediated InflammationOxidative Stress